BioTissue Ocular

BioTissue Ocular We develop innovative Amniotic Membrane products for the management of ocular surface diseases.

BioTissue® is the leader in regenerative biologic therapies and ocular hygiene solutions, helping eye care professionals heal ocular surface conditions, such as keratitis, recurrent corneal erosions, conjunctivochalasis dry eye, pterygium and dry eye.

02/16/2026

Today, we pause to honor the donors whose generosity helps create healing, hope, and second chances.
Your “yes” changes lives in ways words can’t fully capture.
Happy National Donor Day!

Some choices are easy. Come speak with our team at NASAOS on Feb. 18th if you are curious to learn more about AmnioGuard...
02/13/2026

Some choices are easy. Come speak with our team at NASAOS on Feb. 18th if you are curious to learn more about AmnioGuard® for your cases.

This Valentine’s Day, we’re showing our eyes some real love. 👁️💘
02/11/2026

This Valentine’s Day, we’re showing our eyes some real love. 👁️💘

You didn’t choose CAM360 AmnioGraft™ by accident. You chose it because you are an innovator, you act early, and don’t se...
02/06/2026

You didn’t choose CAM360 AmnioGraft™ by accident.
You chose it because you are an innovator, you act early, and don’t settle for standard when patients need more.

Prokera® people just get it. This is what the decision to choose Cryopreserved Amniotic Membrane looks like!
01/20/2026

Prokera® people just get it. This is what the decision to choose Cryopreserved Amniotic Membrane looks like!

01/14/2026

Different patients, different needs.
CAM360 AmnioGraft™ gives Dr. Bauzá a solution that meets patients where they are.

Read more:
🔗 https://brnw.ch/21wZ5ZD

Glaucoma affects intraocular pressure, and while glaucoma drops help lower it, they can also impact the ocular surface. ...
01/12/2026

Glaucoma affects intraocular pressure, and while glaucoma drops help lower it, they can also impact the ocular surface.

Good news? Routine eye exams help monitor both. This is your friendly reminder to schedule yours today!

We’d like to apologize… 😉     1. Data on File. 2. John, T, Tighe, S, Sheha, H. et al. Corneal Nerve Regeneration after S...
01/07/2026

We’d like to apologize… 😉


1. Data on File.

2. John, T, Tighe, S, Sheha, H. et al. Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease. J Ophthalmol. 2017;2017:6404918. https://doi.org/10.1155/2017/6404918

*Note: The FDA has not approved or recognized the precise method of action for HC-HA/PTX3. BioTissue is pursuing Biologics License Applications for its products

01/02/2026

As the year wraps up, we’re reflecting on the impact made possible by those who trust and believe in us—our dedicated physicians, patients, and donors.

Together, we’ve advanced the standard of care.

Happy Holidays from all of us at BioTissue!

12/18/2025

Dry, irritated eyes have become part of your every day, ask your physician about CAM360 AmnioGraft™.

A 2 to 3-day treatment that may help improve your symptoms of Dry Eye Disease.¹



1. Short-Term Outcomes Associated with CAM360 AmnioGraft™: Results from Real-World Evidence. BioTissue Holdings Inc.; 2025. US-CAM360-0110.

12/16/2025

Improved healing takes teamwork & innovative treatment options.
The best outcomes happen when science & skill work together.

12/09/2025

Through the generosity of mothers who donate birth tissue and the dedication of physicians.

Together, they’re sharing the miracle of sight.

Address

7300 Corporate Center Drive, Suite 700
Miami, FL
33126

Alerts

Be the first to know and let us send you an email when BioTissue Ocular posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category